KDKatherine Drabiak

Katherine Drabiak

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Katherine Drabiak has a total of 7 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • State Law Variation Regarding Informed Consent for Sexual Assault Medical Forensic Exams With Adolescents

    by Connie Gao, Katherine Drabiak

    Background: Several states have amended their laws relating to a minor’s ability to consent to medical forensic exams after sexual assault. Aim: To identify state-by-state legal differences of who may provide informed consent for forensic medical exams with adolescent patients following sexual assault. Methods: A search of all 50 states using the legal database Westlaw for state statutes pertaining to who may provide consent for sexual assault medical forensic exams on minors. Results: Unless stated as an exception, parental consent remains a prerequisite for minors to undergo medical forensic exams and medical treatment following a sexual assault. Fourteen states have an exception that allows minors to obtain sexual assault medical forensic exams without parental consent, while twenty-eight states do not have an exception (require parental consent). Discussion: Legislative divergence across states highlights the importance of health care providers to remain current on their state’s requirements.

  • Why clinicians should provide lifesaving treatment after attempted suicide despite patient refusal

    by Katherine Drabiak

    Historically, EMTs and clinicians intervened to resuscitate patients and provide lifesaving treatment following a suicide attempt. Despite this, the literature describes a range of cases following an attempted suicide where some physicians and ethicists assert that clinicians should not resuscitate the patient or provide lifesaving interventions, and instead allow the patient to die. Building upon a recent clinical ethics consultation case, this article provides a taxonomy of cases in the literature of patients who refuse lifesaving treatment following a suicide attempt. Often, these cases occur rapidly in emergency settings, offering little time for deliberation or discussion. While adults with decision-making capacity do have a right to refuse lifesaving treatment, this right does not extend to patients whose capacity is compromised or absent. This article outlines key legal points to guide clinician actions, including considerations for capacity assessments, duties under the Emergency Medical Treatment and Labor Act, the doctrine of presumed consent, and emergency psychiatric hold laws. Integrating legal duties along with ethical principles of autonomy, nonmaleficence, and beneficence, this article provides a model recommendation to guide future cases.

  • Open Access

    Caution Is Warranted in Prescribing Ketamine for Mental Health

    by Katherine Drabiak

    Clinics across the USA advertise ketamine as an alternative solution for mental health conditions. Ketamine has expanded into a multibillion-dollar industry, with three delivery models: (1) in-person clinics offering off-label racemic ketamine; (2) clinic visits for esketamine (Spravato); and (3) telehealth services prescribing off-label racemic ketamine. About half of the market encompasses telehealth using off-label prescribing. This article describes the legal changes behind the growth of telehealth-only providers, differences in patient monitoring requirements, and implications for patient safety. While providers can legally prescribe medications off-label, providers should consider three questions to determine whether off-label prescribing is clinically and ethically appropriate. Providers should evaluate: (1) whether sound evidence exists to prescribe; (2) whether drug benefits outweigh the risks; (3) and whether prescribing serves the patient’s best interests. As a dissociative anesthetic, ketamine raises significant concerns regarding whether the purpose and function of the drug meet legal requirements for appropriate prescribing of controlled substances.


  • Three Roles for Clinical Ethicists to Provide Clarity and Guidance on Physician‐Assisted Suicide/Euthanasia

    by Katherine Drabiak

    A minority of countries around the world have taken steps to legalize the practice of physician‐assisted suicide and/or euthanasia (PAS/E). Proponents frame PAS/E as a means to enhance patient autonomy, reduce suffering, alleviate the burden of illness, and respect patient dignity. Critics of PAS/E, on the other hand, assert that it reflects a distortion of autonomy, mistakes the source of patient suffering, and dangerously affirms to people that their dignity and worth are contingent on not requiring burdensome caregiving. This has the potential to create uncertainty for how clinicians and institutions should provide ethical guidance to patients on morally controversial matters such as PAS/E. Although ethicists have a duty to explain the range of ethical arguments, they also have an obligation to reinforce ethical boundaries and provide decisive guidance when an intervention is irreconcilable with the practice of medicine. In their clinical role, ethicists can explain why PAS/E is not a healing act and why it violates the principles of beneficence and nonmaleficence. This article outlines three roles for clinical ethicists to provide education, consultation, and develop policies designed to respond to patient suffering in a manner that preserves the integrity of medicine.


  • Open Access

    Addressing the Problem of Brain Death Misdiagnosis

    by Marjorie Fitzsimmons, Katherine Drabiak, Prithvi Shetty

    Recent literature describes the controversy relating to brain death/death by neurological criteria (DNC), which some have referred to as “widely accepted, but not universally supported.” This article provides an overview of differences in state laws relating to DNC and describes recent proposals to reform the definition of brain death. In 2023, the American Academy of Neurology (AAN) issued clinical guidelines stating that clinicians may declare a patient DNC despite evidence of neuroendocrine function — a position that directly conflicts with state law requirements for determining death. This article offers a critical analysis of AAN guidelines, an update on proposals to reform the Uniform Determination of Death Act, and explains why policy discussions should include how DNC exams occur in practice. Research suggests there are flaws with current clinical testing methods, which contributes to two separate problems: (1) false positives from insufficient testing, and (2) inadvertent misdiagnosis from unintentional errors. Together, this has produced confusion and reduced public trust in the concept of brain death. This article provides recommendations to clarify and retain the current legal standard for brain death, explains the ethical importance of accurate standards for determining DNC, and offers practical solutions to reduce errors.


  • How clinicians can respond when family members question a proxy/surrogate's judgment and decisional capacity

    by Gregoire Calon, Katherine Drabiak

    Many state laws specify procedures for determining surrogate or proxy decision-makers for end-of-life care in the absence of an advance directive, living will, or other designation. Some laws also set forth criteria that the decision-maker must follow when making medical decisions for an incapacitated patient and determining whether to withdraw life-sustaining treatment. This article provides analysis of a medical ethics case on the question of how to address family allegations that the proxy decision-maker suffers from dementia and is unable to make decisions for the patient. Cases such as this involve interwoven legal and ethical considerations including: how to address concerns that the proxy is making questionable or unreasonable decisions, how to evaluate the proxy's decisional capacity, strategies for enhancing communication, and standards for removing a proxy. This article suggests that “surrogacy ladders” in state law serve not only as a procedural mechanism, but also protect important ethical values such as tiers of moral authority for decision-making, relational autonomy, and privacy.

  • Eight Strategies to Engineer Acceptance of Human Germline Modifications

    by Shoaib Khan, Katherine Drabiak

    Until recently, scientific consensus held firm that genetically manipulated embryos created through methods including Mitochondrial Replacement Therapy or human germline genome editing should not be used to initiate a pregnancy. In countries that have relevant laws pertaining to heritable human germline modifications, the vast majority prohibit or restrict this practice. In the last several years, scholars have observed a transformation of scientific and policy restrictions with insistent calls for creating a regulatory pathway. Multiple stakeholders highlight the role of social consensus and public engagement for governance of heritable human germline modifications. However, in the drive to gain public acceptance and lift restrictions, some proponents provide distorted or misleading narratives designed to influence public perception and incrementally shift the consensus. This article describes eight discrete strategies that proponents employ to influence framing, sway public opinion, and revise policymaking of human germline modifications in a manner that undermines honest engagement.


  • The Problem with Using Medical Boards to Regulate Misinformation

    by Katherine Drabiak

    Some stakeholders called on medical boards to sanction physicians for spreading misinformation during COVID-19 and discussing off-label medications. In 2022, California passed AB 2098, which classifies physician dissemination of misinformation as unprofessional conduct subject to discipline by the state medical board. This article describes the purpose and function of state medical boards, the law relating to off-label prescribing, and why using medical boards to discipline physicians for discussing controversial opinions exceeds the traditional role of state medical boards. Though physicians do have a duty to provide accurate information to the public, defining misinformation is difficult and poses five distinct problems. Although California's law was repealed, this article asserts that disciplining physicians for disseminating misinformation could pose Constitutional concerns, hinder physicians' ability to practice medicine, or suppress information that is important to the public interest.